The Age of Tech x Biopharma

AI and emerging technologies are reshaping biopharma and redefining how science is built, scaled and valued. As the landscape shifts, the industry must confront critical questions about leadership, capital strategy and what innovation really looks like in the years ahead.
BAR | Bay Area Registry is not responsible for the accuracy of information/content posted. Be sure to confirm all information by referring to the original source (event organizer) or performer websites.





